BARD Poly Midline 4154108DRecalls & reported problems
Bard Access Systems, Inc. · Bard Poly Midline 4F Single-Lumen Maximal Barrier Kit (20 cm) · Class 2 · Implant
All models of Bard Poly Midline (9)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00801741037665), received between Aug 18, 2016 and Apr 19, 2017 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Fluid/Blood Leak” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Fluid/Blood Leak1
- Leak/Splash1
Patient problems
- No Known Impact Or Consequence To Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 19, 2017Leak/Splash
IT WAS REPORTED BY THE FACILITY THAT THE CATHETER LEAKED DURING INSERTION WHILE FLUSHING.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 6504548 ↗MalfunctionAug 18, 2016Fluid/Blood Leak
ON 7/26/2016- PER SALES REPRESENTATIVE, USER FACILITY REPORTED THAT A MIDLINE CATHETER LEAKED AFTER TWO DAYS AND WAS REMOVED AND REPLACED. ON 08/08/2016 - FACILITY CONTACT REPORTED THAT THE MIDLINE LEAK WAS LOCATED "OUTSIDE/INSIDE THE LUMEN". CONTACT STATED THAT HE DID NOT NICK THE SKIN BUT NOTICED AFTER A FEW DAYS THAT THE BIO PATCH BECAME WET AFTER THE PATIENT RECEIVED IV ANTIBIOTICS. HE STATED THAT WHEN THE CATHETER WAS FLUSHED, THERE WAS A LEAK COMING FROM THE EXIT SITE. HE REPORTED THAT WHEN HE WAS CHANGING THE DRESSING AND FLUSHED THE LINE, "A SUDDEN GUSH OF BLOOD CAME OUT FROM THE EXIT SITE". HE REPORTED HE INSERTED THIS LINE. THE CATHETER WAS DISCONTINUED AND HE NOTICED THE CATHETER WAS "CROOKED, NOT STRAIGHT." ON 08/08/2016 - FACILITY CONTACT REPORTED THAT THE CATHETER WAS PLACED IN THE UPPER ARM AND NEVER IN THE AC. THEY USE THE BASILICA OR CEPHALIC VEIN.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 5886834 ↗
Other Catheter,intravascular,therapeutic,long-term greater than 30 days devices
- Groshong NXT ClearVue Catheter 7617405Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days2 deaths1,708 reports
- Groshong NXT ClearVue Catheter 7655405Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days2 deaths1,536 reports
- PowerPICC Catheter 3174118Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days1 recall402 reports
- L-Cath™ S/L PICC S/L 26GA (1.9F) x 30cmArgon Medical Devices, Inc. · Catheter,Intravascular,Therapeutic,Long-Term Greater Than 30 Days2 recalls245 reports
- PowerPICC SOLO2 Catheter 1194108DBard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days2 recalls216 reports
- Broviac 0600520Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days1 recall265 reports
- Groshong® Catheter 7717405Bard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days279 reports
- PowerPICC® Catheters 1174108DBard Access Systems, Inc. · Catheter,intravascular,therapeutic,long-term greater than 30 days1 recall222 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page